1 asset in Glycoprotein Metabolism Disease

Therapeutic assets addressing Glycoprotein Metabolism Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Glycoprotein Metabolism Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (53)